Headless C1q: a new molecular tool to decipher its collagen-like functions

Guillaume Fouët1, Isabelle Bally1, Luca Signor1

  • 1CEA, CNRS, IBS, Université Grenoble Alpes, Grenoble, France.

The FEBS Journal
|September 2, 2020
PubMed

Insights

Researchers created a new recombinant human C1q protein, CLR_nc2, by replacing its globular heads with a collagen domain. This engineered protein retains the collagen-like region

Area of Science:

  • Immunology
  • Structural Biology
  • Biochemistry

Background:

  • Complement component C1q initiates the classical complement pathway.
  • C1q comprises collagen-like (CLR) and globular (GR) regions, crucial for target recognition and immune response.
  • The GRs bind diverse targets, while CLRs interact with cellular/soluble partners.

Purpose of the Study:

  • To generate the first recombinant human C1q lacking its globular heads.
  • To substitute the C1q GR with the noncollagenous domain 2 (nc2) of type IX collagen.
  • To assess the assembly, folding, and functional properties of the resulting CLR_nc2 recombinant protein.

Main Methods:

  • Protein engineering: Substitution of C1q GR with type IX collagen nc2 domain.
  • Expression in EXPI293 mammalian cells.
  • Characterization using mass spectrometry, mass photometry, and electron microscopy.
  • Interaction analysis via surface plasmon resonance with C1r/C1s and MAp44.

Main Results:

  • Successfully generated and produced the CLR_nc2 recombinant protein.
  • Confirmed correct assembly and folding of CLR_nc2.
  • Demonstrated that CLR_nc2 retains the functional properties of the native C1q CLR in binding known ligands.

Conclusions:

  • The CLR_nc2 recombinant protein serves as a valuable tool for studying C1q's collagen-like region functions.
  • This engineered protein maintains the essential interaction capabilities of the native CLR.
  • Provides insights into the structure-function relationship of C1q in complement activation.